-
Use of Donor-Derived Cell-Free DNA in Children with Kidney Transplantation: A Pilot Study
-
Use of Granulocyte Colony Stimulating Factor After Lung Transplantation is Not Associated with Increased Likelihood of Acute Cellular Rejection
-
Use of Hepatitis B N.A.T. Positive Kidneys in Hepatitis B Immune Recipients
-
Use of Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients: A Scoping Review
-
Use of Microbial Cell Free DNA Sequencing in Solid Organ Transplant Patients
-
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies
-
Utility of Follow-up Biopsies After Acute Rejection in Pediatric Kidney Transplantation
-
Utility of Non-Invasive Rejection Biomarkers to Guide Immunomodulation in Kidney Transplant Patients with Active Covid-19 Infection
-
Utility of Screening-Bead Assay in Post-Transplant Testing of Donor-Specific Antibodies (DSA) and Antibody-mediated Rejection (ABMR) in Renal Allografts
-
Utilization of Donor-Derived Cell-Free DNA Testing in Kidney Transplantation: Do One Month Values Have Any Prognostic Significance?
2021 American Transplant Congress
June 4-9, 2021
ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.